skip to main content

Easy Read panel

The Roald Dahl Centre​ in Liverpool gives advice and care to patients with problems with their blood flow and clotting. Find out more on this page.

Who we are

The Roald Dahl Haemostasis and Thrombosis Centre​ in Liverpool was opened in July 2001. Funded by the Roald Dahl Foundation, this physical structure has enabled better administration of our services in Coagulation Medicine.  

We have also forged further clinical and research links. The Centre is one of only 26 nationally accredited Haemophilia Comprehensive Care Centres. We are a Reference Centre for the Merseyside and North Wales region. We take referrals from across this whole area for patients with bleeding disorders. 

We provide advice diagnosis and on going care. The clinical spectrum encompasses patients with severe thrombotic problems of both congenital and acquired aetiologies.

The Centre has placed a strong focus on the patient environment being comfortable and welcoming. We have been awarded grants that have enabled us to develop our patient areas in this way.

    What we treat

What are Haemoglobinopathies

Haemoglobinopathies refers to a range of genetically inherited disorders of red blood cell haemoglobin and includes sickle cell disease and the thalassaemias

Sickle cell disease and beta thalassaemia major are two of the commonest forms of these genetically inherited disorders.

They occur most commonly in populations whose ancestors come from

Africa, Asia, Mediterranean Islands, Middle and Far East, because of migration and intermarriage they are also seen in the Caribbean, South America and other parts of the world including Britain and North America. Alpha thalassaemia is most common in South East Asia, Hong Kong and China. In the UK an estimated one in 300 babies of African-Caribbean parents and one in 60 of West African parents are born with sickle cell disease each year. 

An estimated 8,000-10,000 people with sickle cell disease and 600 with thalassaemia major live in the UK.

Approximately 1 in 4 West African, 1 in 10 African-Caribbean, 1 in 50 Asian and 1 in 100 Northern Greek have sickle cell trait (carrier state). Whilst 1 in 7 Greek, 1 in 10-20 Asian, 1 in 50 African and African-Caribbean and 1 in 1000 English people have beta thalassaemia trait. Worldwide a thalassaemia carrier states are commoner than ß thalassaemia carrier states.